Clinical Trials for Chiesi

Explore 48 clinical trials worldwide

Showing 1-48 of 48 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Chiesi

Clinical Trials (48)

NCT07109375
Observational Study on Long-term Use of Pegunigalsidase Alfa in Fabry Patients in a Real-world Setting
N/ANot yet recruiting
75 participants
Started: Jan 31, 2026 · Completed: Nov 30, 2028
1 condition1 sponsor1 location
NCT07181382
Efficacy and Safety of Seralutinib in Adult Subjects With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
PHASE3Not yet recruiting
480 participants
Started: Dec 31, 2025 · Completed: Dec 31, 2028
1 condition2 sponsors0 locations
NCT07176117
Surfactant Using a Supraglottic Airway Device in Late Preterm to Early Term Infants
NANot yet recruiting
422 participants
Started: Oct 1, 2025 · Completed: Jun 30, 2031
2 conditions2 sponsors3 locations
NCT06908421
Efficacy of a Smart add-on Device in Combination With a Triple Treatment in Asthma Patients on Inhaler Technique and Adherence
N/ARecruiting
60 participants
Started: Sep 15, 2025 · Completed: Sep 30, 2027
1 condition2 sponsors2 locations
NCT07163182
Evaluation of Safety, Side Effects and How the Drug CHF6467 Administered Via Intranasal Route is Absorbed, Modified and Removed in Healthy Subjects
PHASE1Recruiting
68 participants
Started: Sep 15, 2025 · Completed: Aug 11, 2026
1 condition1 sponsor1 location
NCT06788613
Utilising Hull Lung Health Study Data to Investigate the Performance of TidalSense Diagnostic Algorithms to Identify COPD and Pre-COPD Among Participants in the FRONTIER Programme.
N/ANot yet recruiting
1,200 participants
Started: Aug 31, 2025 · Completed: Sep 30, 2026
3 conditions4 sponsors0 locations
NCT07070167
Bedside Ultrasound to Monitor Lung Function and Blood Flow in Newborns Treated With Surfactant
N/ANot yet recruiting
200 participants
Started: Aug 30, 2025 · Completed: Dec 30, 2026
2 conditions2 sponsors2 locations
NCT06328608
A Study to Learn About the Safety and Effects of the Study Drug PRX-102 in Children and Adolescents With Fabry Disease
PHASE2/PHASE3Recruiting
22 participants
Started: Jul 29, 2025 · Completed: Apr 30, 2031
1 condition2 sponsors11 locations
NCT06941025
Maternal and Postnatal Outcomes Study (MOS): A Global Observational Registry Assessing the Safety of Elfabrio® in Women With Fabry Disease and Their Infants During Pregnancy and Breastfeeding
N/ANot yet recruiting
10 participants
Started: Jun 30, 2025 · Completed: Dec 31, 2034
3 conditions2 sponsors5 locations
NCT06960824
Real-word Study of the de NOVO Extended-release tacrolimuS in Kidney Transplantation Using an ARTificial Intelligence
N/ANot yet recruiting
165 participants
Started: May 31, 2025 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT06833463
Tacrolimus and Risk Factors for Glucose Metabolism Disorders in Kidney Transplant Patients
N/ARecruiting
120 participants
Started: May 29, 2025 · Completed: Jan 30, 2028
1 condition1 sponsor6 locations
NCT06931899
Oscillometry in the COPD Exacerbator Phenotype With Triple Inhaled Therapy Study
N/ANot yet recruiting
63 participants
Started: Apr 30, 2025 · Completed: Aug 31, 2026
1 condition3 sponsors1 location
NCT06917690
A Study to Learn About the Safety and Efficacy of the Drug Oleogel-S10 in Japanese Patients With Epidermolysis Bullosa
PHASE3Recruiting
6 participants
Started: Apr 18, 2025 · Completed: Sep 30, 2029
10 conditions1 sponsor3 locations
NCT06900816
A Comparison Study Between Adolescents With Asthma and Adults With Asthma on How They Absorb, Metabolise and Eliminate CHF 6001
PHASE2Recruiting
50 participants
Started: Mar 28, 2025 · Completed: Nov 30, 2025
1 condition1 sponsor1 location
NCT06840522
The Importance of Tailored Education And Device Handling for Asthmatic Patients
N/ANot yet recruiting
250 participants
Started: Mar 1, 2025 · Completed: Aug 1, 2026
1 condition1 sponsor6 locations
NCT06184503
Analysis of Velmanase Alfa (Lamzede®)'s Effects in the Body of Children With Alpha-Mannosidosis Under the Age 3
N/ARecruiting
5 participants
Started: Feb 19, 2025 · Completed: Sep 30, 2029
1 condition1 sponsor2 locations
NCT06786767
Fixed Triple Inhaled Combination in Asthmatic Patients in a Real-life Setting
N/AActive, not recruiting
281 participants
Started: Feb 1, 2025 · Completed: Feb 15, 2026
3 conditions1 sponsor14 locations
NCT06746064
A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Inhaled CHF10073 After Single and Multiple Doses in Healthy Volunteers and the Effect of Itraconazole on CHF10073 Exposure
PHASE1Recruiting
156 participants
Started: Jan 13, 2025 · Completed: Jan 29, 2026
1 condition1 sponsor1 location
NCT06423573
A Study to Assess the Incidence of Skin Cancers in Patients With Epidermolysis Bullosa Receiving Filsuvez
N/ARecruiting
580 participants
Started: Dec 18, 2024 · Completed: Aug 1, 2032
2 conditions2 sponsors5 locations
NCT06663358
A Multi-Country Observational Study of Safety and Effectiveness of Elfabrio® in Fabry Patients
N/ARecruiting
100 participants
Started: Nov 6, 2024 · Completed: Nov 30, 2029
1 condition1 sponsor1 location
NCT07042035
Study of Tacrolimus Melt-Dose® for Lung Transplant Patients
N/ARecruiting
240 participants
Started: Oct 29, 2024 · Completed: Dec 31, 2026
2 conditions2 sponsors2 locations
NCT06678191
Investigation of Fixed Triple Inhaled Combination in Asthmatic Patients, in a Real-life Setting
N/ARecruiting
800 participants
Started: Oct 24, 2024 · Completed: Aug 31, 2027
2 conditions1 sponsor45 locations
NCT06567977
TriMaximize: A Multicentre, Prospective, Non-interventional Trial in Asthma Patients
N/ARecruiting
60 participants
Started: Aug 31, 2024 · Completed: Aug 1, 2025
1 condition2 sponsors1 location
NCT06480890
Real-World Effectiveness of a Triple Combination BDP/FF/GB in a Single Pressurised Metered Dose Inhaler in COPD Patients (TRIPHY)
N/AActive, not recruiting
359 participants
Started: Jul 2, 2024 · Completed: Oct 15, 2025
1 condition1 sponsor18 locations
NCT06421506
Less Invasive Surfactant Administration in Late Preterm or Early Term Born Infants
NANot yet recruiting
245 participants
Started: May 31, 2024 · Completed: Sep 30, 2026
3 conditions2 sponsors0 locations
NCT06100042
Observational Study on Therapy Pathways of Asthamics Treated With ICS/LABA/LAMA Therapy in a Real-world Setting
N/AActive, not recruiting
200 participants
Started: Apr 24, 2024 · Completed: Jun 30, 2026
1 condition2 sponsors1 location
NCT06313372
Interpreting Respiratory Oscillometry in Adult Asthma and COPD: a Delphi Study
N/ANot yet recruiting
50 participants
Started: Mar 31, 2024 · Completed: Jan 31, 2025
2 conditions2 sponsors0 locations
NCT06268769
Tacrolimus C:D Ratio Measured in Renal Transplant Recipients Treated With Once-daily Prolonged-release Drugs
PHASE4Recruiting
300 participants
Started: Mar 9, 2024 · Completed: Sep 30, 2029
1 condition2 sponsors9 locations
NCT06188065
Eosinopenia in Severe COPD Exacerbation
N/ARecruiting
200 participants
Started: Jan 22, 2024 · Completed: Jul 31, 2026
1 condition4 sponsors1 location
NCT06007547
Prophylactic Minimally Invasive Surfactant Evaluation
PHASE4Recruiting
200 participants
Started: Jan 1, 2024 · Completed: Jul 31, 2027
2 conditions2 sponsors1 location
NCT06166056
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Inhaled CHF6333 After Single Doses in Healthy Volunteers and After Single and Repeated Doses in Subjects With Bronchiectasis
PHASE1/PHASE2Recruiting
45 participants
Started: Nov 29, 2023 · Completed: Apr 30, 2026
1 condition1 sponsor9 locations
NCT06029595
Efficacy and Safety of Tanimilast in Asthmatics uNcontrolled on ICS-containinG backgrOund Maintenance Therapy
PHASE2Active, not recruiting
464 participants
Started: Nov 26, 2023 · Completed: Feb 17, 2027
1 condition1 sponsor187 locations
NCT06095713
German Observational Multicenter Study of Patients With Fabry Disease Under Enzyme Replacement Therapy With Pegunigalsidase-alfa
N/ARecruiting
60 participants
Started: Oct 1, 2023 · Completed: Sep 30, 2027
1 condition2 sponsors8 locations
NCT05710692
Study to Evaluate the Safety, PK, PD, and Efficacy of PRX-102 in Japanese Patients With Fabry Disease
PHASE2/PHASE3Recruiting
18 participants
Started: Aug 1, 2023 · Completed: Mar 31, 2028
1 condition2 sponsors9 locations
NCT05948891
Impact of Fixed TRIple Therapy With Beclometasone/Formoterol/Glycopyrronium DPI (Trimbow® in NEXThaler Device) in Chronic Obstructive PulmoNary Disease in rEal-world Settings: Health-related Quality of Life Patient' eXpectations and characterisTics: the TriNEXT Study
N/ARecruiting
500 participants
Started: Aug 1, 2023 · Completed: Mar 31, 2025
1 condition2 sponsors1 location
NCT05744635
Assessment of the Pharmacokinetic Profile of Tacrolimus Medications and Their Relation to Effectiveness and Safety in Liver Transplant Patients
N/ARecruiting
110 participants
Started: May 10, 2023 · Completed: Jun 1, 2026
1 condition2 sponsors2 locations
NCT05652439
PASS to Assess Cardiovascular and Cerebrovascular Events in COPD Patients Initiating Fixed Triple Therapy (DPI or pMDI)
N/ARecruiting
25,000 participants
Started: Dec 2, 2022 · Completed: Aug 31, 2026
1 condition1 sponsor1 location
NCT04320342
A Study Comparing Efficacy, Safety and Tolerability of the Fixed Dose Triple Combination CHF 5993 With the Fixed Dose Dual Combination CHF 1535 in Subjects With COPD
PHASE3Active, not recruiting
3,433 participants
Started: Apr 28, 2022 · Completed: Jan 31, 2026
2 conditions1 sponsor436 locations
NCT07046442
Effect of Pulmonary Rehabilitation and Physical Activity on Long COVID (PuReCOVID)
N/AActive, not recruiting
40 participants
Started: Apr 5, 2022 · Completed: Dec 30, 2025
1 condition2 sponsors1 location
NCT04636801
A 52-week, Placebo-controlled Study to Evaluate the Efficacy and Safety of 2 Doses of CHF6001 DPI (Tanimilast), as add-on to Maintenance Triple Therapy in Subjects With COPD and Chronic Bronchitis (PILASTER)
PHASE3Active, not recruiting
3,435 participants
Started: Jul 14, 2021 · Completed: Jan 5, 2026
1 condition1 sponsor447 locations
NCT04636814
A 52-week, Placebo- and Active- Controlled (Roflumilast, Daliresp® 500µg) Study to Evaluate the Efficacy and Safety of Two Doses of CHF6001 DPI (Tanimilast) as add-on to Maintenance Triple Therapy in Subjects With COPD and Chronic Bronchitis. (PILLAR)
PHASE3Active, not recruiting
3,973 participants
Started: Jul 12, 2021 · Completed: Dec 26, 2025
1 condition1 sponsor460 locations
NCT04720326
Bioavailability and Practicability of Envarsus Versus Advagraf in Liver Transplant Recipients
PHASE4Active, not recruiting
268 participants
Started: Dec 23, 2020 · Completed: Oct 31, 2026
1 condition3 sponsors15 locations
NCT04458038
Does Chronic Obstructive Lung Disease Influence the Cognitive Function
NAActive, not recruiting
102 participants
Started: Dec 7, 2020 · Completed: Dec 31, 2023
1 condition4 sponsors1 location
NCT04246060
Observational Study to Assess the Quality of Life in Nephropathic Cystinosis Patients
N/AEnrolling by invitation
31 participants
Started: Jul 31, 2020 · Completed: Jul 1, 2026
1 condition1 sponsor7 locations
NCT04526431
Tacrolimus Pharmacokinetic Subpopulations
N/ARecruiting
180 participants
Started: Jul 28, 2020 · Completed: Aug 1, 2027
2 conditions2 sponsors2 locations
NCT04076813
Cangrelor in Acute Myocardial Infarction: Effectiveness and Outcomes Registry
N/AActive, not recruiting
5,050 participants
Started: Oct 16, 2019 · Completed: Jun 30, 2025
1 condition2 sponsors11 locations
NCT03614234
Open Label Extension of 2 mg/kg Pegunigalsidase Alfa (PRX-102) Every 4 Weeks in Adult Fabry Disease Patients
PHASE3Active, not recruiting
29 participants
Started: Nov 13, 2018 · Completed: Mar 28, 2026
1 condition1 sponsor14 locations
NCT06035289
Register Schweres Asthma - German Asthma Net e.V.
N/ARecruiting
4,500 participants
Started: Nov 1, 2011 · Completed: Nov 1, 2026
1 condition5 sponsors45 locations